Beranda › Kanker Paru › California › Mountain View
Uji klinis Kanker Paru di Mountain View, CA
17 studi untuk Kanker Paru mencari peserta di lokasi sekitar Mountain View (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Menerima pesertaFase 3
- Palo Alto Medical Foundation-Camino Division, Mountain View
- Palo Alto Medical Foundation Health Care, Palo Alto · 5 mi jauhnya
- Stanford Cancer Institute Palo Alto, Palo Alto · 5 mi jauhnya
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Menerima pesertaFase 3
- Stanford Cancer Institute Palo Alto, Palo Alto · 5 mi jauhnya
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
Menerima pesertaFase 2
- Stanford Cancer Institute, Stanford · 5 mi jauhnya
- Stanford Hospital and Clinics, Stanford · 5 mi jauhnya
- Stanford Hospital Investigational Drug Services, Stanford · 5 mi jauhnya
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Menerima pesertaFase 1/2
- Stanford Cancer Institute, Stanford · 5 mi jauhnya
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Menerima pesertaFase 3
- Palo Alto Medical Foundation Research Center, Palo Alto · 5 mi jauhnya
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Menerima pesertaFase 3
- Palo Alto Medical Foundation-Camino Division, Mountain View
- Palo Alto Medical Foundation Health Care, Palo Alto · 5 mi jauhnya
Safety and Efficacy of OBX-115 in Advanced Solid Tumors
Menerima pesertaFase 1/2
- Stanford Cancer Institute (Melanoma/NSCLC), Stanford · 5 mi jauhnya
Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.
Menerima peserta
- VA Palo Alto Health Care System, Palo Alto · 5 mi jauhnya
Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers
Menerima pesertaStudi observasional
- Stanford University School of Medicine, Stanford · 5 mi jauhnya
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Menerima pesertaFase 1/2
- Stanford University - Stanford Cancer Institute, Stanford · 5 mi jauhnya
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Menerima pesertaFase 1/2
- Stanford University, Stanford · 5 mi jauhnya
Delayed or Upfront Brain RAdiotherapy in Treatment naïve Lung Cancer Patients With Asymptomatic or Minimally Symptomatic Brain Metastases and ALK rEarrangements
Menerima pesertaFase 1/2
- Stanford University, Stanford · 5 mi jauhnya
Personalized Accelerated ChEmoRadiation (PACER) for Lung Cancer
Menerima pesertaFase 1
- Stanford University, Palo Alto · 5 mi jauhnya
Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers
Menerima pesertaSukarelawan sehat diterima
- Standard University, Stanford · 5 mi jauhnya
Engagement of Veterans With Lung Cancer
Menerima peserta
- Veterans Affairs Palo Alto Health Care System (VAPAHCS), Palo Alto · 5 mi jauhnya
Panitumumab-IRDye800 in Detecting Cancer in Participants With Lung Cancer During Surgery
Menerima pesertaFase 1/2
- Stanford University, School of Medicine, Palo Alto · 5 mi jauhnya
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Menerima pesertaStudi observasional
- Massive Bio SYNERGY-AI site, Stanford · 5 mi jauhnya
Uji klinis Kanker Paru di kota lain
- Houston, TX78 studi
- Boston, MA62 studi
- New York City, NY60 studi
- Los Angeles, CA45 studi
- Washington, DC41 studi
- Arlington, VA41 studi
- Chicago, IL41 studi
- Nashville, TN40 studi
- Baltimore, MD40 studi
- St. Louis, MO39 studi
- Columbus, OH37 studi
- Philadelphia, PA36 studi
Studi lain di Mountain View
- Kanker (semua jenis)40 studi
- Kanker Payudara25 studi
- Kanker Metastatik25 studi
- Kanker Paru Non-Sel Kecil21 studi
- Leukemia Mieloid Akut19 studi
- Kanker Ovarium19 studi
- Gangguan Spektrum Autisme17 studi
- Gagal Jantung15 studi
- Kanker Prostat15 studi
- Autisme13 studi
- Leukemia Limfoblastik Akut13 studi
- Kanker Kolorektal13 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.